Un hombre de mediana edad con un traje oscuro a rayas, camisa azul claro y corbata a rayas sonríe a la cámara en un moderno despacho de abogados corporativos.

Michael J. Tuteur

Socio/Jubilado

Michael J. Tuteur

Socio/Jubilado

Mike Tuteur has spent nearly 40 years successfully trying cases and arguing appeals in both civil and criminal courts around the country. He is sought after for his seasoned judgment, trial experience, and litigation victories. Mike served as chair of the firm’s national Litigation Department from 2009 to 2015, as well as chair of its Commercial Litigation Practice. He is a partner in the Government Enforcement Defense & Investigation Practice and a former member of the firm’s national Management Committee.

Mike represents a broad range of clients, with a particular focus on health care litigation, False Claims Act defense, government and internal investigations, and scientific and research misconduct. He has recently been involved in FCA matters involving Medicare Advantage as well as assisting various health care entities, including “High Impact Target” hospitals, avoiding FCA liability in connection with the CARES Act, the Paycheck Protection Program, and the Health Care Enhancement Act.

Mike’s extensive experience includes ERISA and RICO class actions, False Claims Act (FCA) litigation, and the defense of both organizations and individuals in Justice Department and SEC investigations. He is particularly skilled in investigating and defending academic institutions in connection with claims of scientific misconduct and research misconduct. And he was named “Lawyer of the Year” in Boston for Bet-the-Company Litigation in both 2018 and 2020 by Best Lawyers in America.

Earlier in his career, Mike served as an Assistant U.S. Attorney in the Major Crimes and Organized Crime Strike Force units of the U.S. Attorney’s office in Boston. Between his prosecutorial experience and his private practice, Mike has tried more than 20 cases to decision. He has also argued nearly 20 appeals in state and federal appellate courts across the country.

Mike has been appointed a Special Assistant Attorney General on several occasions, including four appointments to represent Massachusetts Govs. William F. Weld and A. Paul Cellucci in constitutional cases involving the scope and effect of the governor’s veto power. A U.S. District Judge appointed Mike to investigate allegations of document destruction and attorney misconduct. Mike also served as an expert witness to the Royal Courts of Justice in London to give opinion evidence on the application of U.S. law to the Latin American syndicated debt market.

“He’s a terrific, standout lawyer and very intelligent,” according to Chambers & Partners, USA. “His experience, his writing and his judgment are all strong.”

Mike received his A.B. from Harvard College, summa cum laude, and his J.D. from Harvard Law School, magna cum laude. He now serves as a trial adviser at Harvard Law School’s Trial Advocacy Workshop and judges its Ames Moot Court program. He also has taught at the Harvard School of Public Health’s Continuing Education Program on Corporate Compliance and is a frequent writer and speaker on civil and criminal jurisprudence, with a special emphasis on the law of research and scientific misconduct.

Mike has devoted significant time to litigating special education cases on a pro bono basis. He has helped make new law in the First Circuit on behalf of special needs families who have been forced by financial constraints to leave their place of residence. For his pro bono work, the Massachusetts Supreme Judicial Court’s Standing Committee on Pro Bono Legal Services awarded Mike its Certificate of Recognition in 2007.

Mike is a member and former chair of the Advisory Board of the Smithsonian Astrophysical Observatory, a component of the Center for Astrophysics | Harvard & Smithsonian and serves on the Smithsonian New England Regional Council.

Premios y reconocimientos

  • Named Best Lawyers® 2018 and 2020 Bet-the-Company Litigation “Lawyer of the Year” in Boston
  • Seleccionado por sus homólogos para su inclusión en The Best Lawyers in America® en los campos de:
    • Bet-the-Company Litigation (2010-2024)
    • Commercial Litigation (2007, 2010-2024)
    • Criminal Defense: White-Collar (2007, 2011, 2013-2023)
    • Health Care Law (2018-2023)
  • Recognized in Chambers USA: Los mejores abogados de EE.UU. para los negocios in the practice areas of:
    • Litigation: General Commercial (2004-2024)
    • Litigation: White-Collar Crime & Government Investigations (2004-2015)
  • Top 100 Massachusetts Super Lawyers® (2004-present)

Presentaciones y publicaciones

  • Co-author, “The 25th Anniversary of the Business Litigation Session: A Look Back,” Boston Bar Journal (Fall 2024)
  • Coautor, "Ensayos clínicos descentralizados: Research Misconduct Risks & How to Avoid Them", Health Care Law Today (30 de septiembre de 2024).
  • Co-author, “Medicare Advantage: A Circuit Court Addresses What is (or is not) Material in False Claims Act Cases,” Health Care Law Today (September 18, 2024)
  • Co-author, “Business Litigation Session 2023 Year in Review,” Mass. Lawyers Weekly.
  • Author, “‘Let’s Talk Compliance’: Medicare Advantage: Compliance Issues and Enforcement” Health Care Law Today (March 12, 2024)
  • Co-author, “HRSA Uninsured Program COVID-19 Services: What Were the Standards to Determine Uninsured Status?” The National Law Review (August 17, 2023)
  • Speaker, “Supreme Court’s EPA Ruling Jeopardizes Healthcare Regulations,” Modern Healthcare (July 12, 2022)
  • Co-author, “Massachusetts Business Litigation Session,” American Bar Association Recent Developments in Business Courts 2022 (February 2, 2022)
  • Co-author, “Protecting Your Institution from False Claims Act Allegations After Receipt of CARES Act Funding,” American Health Law Association (November 11, 2020)
  • Co-author, “Year in review: the Business Litigation Session, 2019,” Massachusetts Lawyers Weekly (January 2020)
  • Co-author, “Provisional Remedies,” Practical Law (October 2019)
  • Co-author, “Commencing an Action: Massachusetts,” Practical Law (April 2019)
  • Panelist/speaker: The Business Litigation Session: Year in Review 2018, presented by Social Law Library and Mass. Lawyers Weekly (January 2019)
  • Co-author, “That ‘Hot’ Research Project May Land Your Lab in Hot Water,” Compliance Today (November 2018)
  • Co-author, “Responding to a Complaint: Massachusetts,” Practical Law (November 2018)
  • Co-author, “Q&A Litigation Overview: Massachusetts,” Practical Law (October 2018)
  • Panelist, “Government Sponsored Research, Research Integrity, and the False Claims Act,” ABA National Institute to the Civil False Claims Act (June 2018)
  • Panelist, “Understanding the Difference Between Scientific Research, Misconduct and Fraud,” ACC (June 19, 2018)
  • Co-author, “Scientific research misconduct vs. fraud: How to tell the difference.” Compliance Today (May 2018)
  • Co-author, “The Business Litigation Session Year in Review,” Massachusetts Lawyers Weekly (January 4, 2018)
  • Speaker, “Exhibit (Facebook): The Impact of Social Media on Civil Litigation,” Boston Bar Association (October 6, 2016)
  • Speaker, “Use and Misuse of ERISA in Out-of-Network Litigation,” Blue Cross Blue Shield Summit (May 17, 2016)
  • Speaker, “World Recognition of Distinguished General Counsel,” The Directors Roundtable (February 2, 2014)
2 de julio de 2025 Pro Bono

Foley consigue una victoria pro bono que permite la graduación de un alumno de educación especial

Foley & Lardner LLP consiguió una victoria pro bono al obtener apoyo educativo crítico para un estudiante de educación especial. Como resultado de la intervención de Foley y el litigio iniciado siete años antes, el cliente pudo graduarse recientemente con un diploma de escuela secundaria y participar en las ceremonias de graduación.
Un conjunto de tubos de ensayo con líquido azul dispuestos en una gradilla blanca sobre una mesa de laboratorio, rodeados de otros instrumentos de vidrio, evoca la precisión que suele encontrarse en los despachos de abogados especializados en propiedad intelectual.
September 30, 2024 Health Care Law Today

Ensayos clínicos descentralizados: riesgos de conducta indebida en la investigación y cómo evitarlos

La pandemia de COVID-19 obligó al sector sanitario a adaptarse para ofrecer atención remota a los pacientes, incluidos los que participaban en ensayos clínicos, y el uso de ensayos clínicos descentralizados proliferó durante la pandemia.
September 24, 2024 Health Care Law Today

Conducta indebida en la investigación: la ORI publica la norma definitiva con regulaciones modernizadas y simplificadas

El 17 de septiembre de 2024, la Oficina de Integridad en la Investigación (ORI) publicó una norma definitiva por la que se adoptaban cambios en la normativa federal que regula las conductas indebidas en la investigación financiada con fondos federales (Norma definitiva).
Primer plano de un clip que sujeta una tarjeta y documentos de Medicare, con la inscripción "Medicare" claramente visible: una imagen que suele verse en un bufete de abogados o entre los abogados de Chicago que manejan información confidencial de sus clientes.
September 18, 2024 Health Care Law Today

Medicare Advantage: un tribunal de apelación aborda lo que es (o no es) relevante en los casos relacionados con la Ley de Reclamaciones Falsas.

El 13 de septiembre de 2024, la Corte de Apelaciones del Octavo Circuito de los Estados Unidos publicó su tan esperada decisión en el caso United States ex rel. Holt v. Medicare Medicaid Advisors, en la que confirmó la desestimación por parte del Distrito Oeste de Missouri de un caso relacionado con Medicare Advantage, lo que supuso una victoria para las partes interesadas en la atención médica gestionada, especialmente las compañías de seguros, los corredores de seguros y las organizaciones de comercialización de seguros.
6 de junio de 2024 Comunicados de prensa

Foley alcanza los primeros puestos en Chambers USA 2024

Foley & Lardner LLP se complace en anunciar que vuelve a ser reconocido por Chambers & Partners como uno de los despachos líderes del país en la edición 2024 de Chambers USA, America's Leading Lawyers for Business.
Un estetoscopio descansa sobre una hoja de papel en la que se muestran gráficos de barras y líneas azules, lo que sugiere una conexión entre el análisis de datos sanitarios y el apoyo en litigios en bufetes de abogados.
March 12, 2024 Health Care Law Today

«Hablemos sobre el cumplimiento»: Medicare Advantage: cuestiones de cumplimiento y aplicación de la ley

Durante la tercera sesión de la serie Let’s Talk Compliance, Valerie Rock, directora de PYA, y Michael Tuteur, socio de Foley and Lardner, hablaron sobre el panorama cambiante relacionado con el escrutinio y la supervisión gubernamentales en torno a los planes Medicare Advantage (MA) y sus pagos.